Zobrazeno 1 - 10
of 92
pro vyhledávání: '"F. Gietzen"'
Autor:
Sebastian Barth, Michael Zacher, F. Gietzen, Daniel P. Griese, Sebastian Kerber, Bernhard Schieffer, Martina B. Hautmann, Wilko Reents, Philipp Halbfass, Karsten Hamm
Publikováno v:
Catheterization and Cardiovascular Interventions. 90:1038-1045
Objectives This study sought to investigate whether the percutaneous mitral regurgitation (MR) reduction with the MitraClip® system in end-stage heart failure patients with a left ventricular ejection fraction (LVEF) of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4102b7975ab300a3103d6f37c8cff61
https://doi.org/10.1002/ccd.27159
https://doi.org/10.1002/ccd.27159
Autor:
K. Sonne, F. Gietzen, Karin Nentwich, S. Barth, M. Roos, Lukas Lehmkuhl, K. Hamm, Elena Ene, S. Fodor, Philipp Halbfaß, T. Deneke
Publikováno v:
Herzschrittmachertherapie + Elektrophysiologie. 28:212-218
Ventricular tachycardias (VT) in patients with structural heart diseases have predominantly a scar-associated reentry mechanism so that substrate-based ablation approaches also have to be used in nearly all procedures. In many VT cases-especially in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31a2cb9b69158fe76fbd2db7f17cd690
https://doi.org/10.1007/s00399-017-0501-7
https://doi.org/10.1007/s00399-017-0501-7
Autor:
Karsten Hamm, Sebastian Barth, Michael Zacher, F. Gietzen, Martina B. Hautmann, Sebastian Kerber, Anno Diegeler, Bernhard Schieffer, Philipp Halbfass
Publikováno v:
Catheterization and Cardiovascular Interventions. 90:313-320
Objectives: We sought to determine the effects of experience on the Mitraclip® procedure steps as well as procedure safety and functional results. Background: MR has proven deleterious in heart failure. Mitraclip® therapy evolved an important optio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9237912d35eb1e6e110de0b4174efc66
https://doi.org/10.1002/ccd.26806
https://doi.org/10.1002/ccd.26806
Autor:
E, Ene, P, Halbfaß, K, Nentwich, K, Sonne, M, Roos, S, Fodor, L, Lehmkuhl, F, Gietzen, S, Barth, K, Hamm, T, Deneke
Publikováno v:
HerzschrittmachertherapieElektrophysiologie. 28(2)
Ventricular tachycardias (VT) in patients with structural heart diseases have predominantly a scar-associated reentry mechanism so that substrate-based ablation approaches also have to be used in nearly all procedures. In many VT cases-especially in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e8bbd033c314a6f085e0dae8b4e5a70
https://pubmed.ncbi.nlm.nih.gov/28488109
https://pubmed.ncbi.nlm.nih.gov/28488109
Autor:
Martina B. Hautmann, Thomas Deneke, Michael Zacher, Philipp Halbfass, F. Gietzen, Bernhard Schieffer, Holger Reinecke, Anja Schade, Karsten Hamm, Sebastian Kerber, Sebastian Barth
Publikováno v:
Obesity researchclinical practice. 11(4)
Aim The aim of our comprehensive single centre analysis was to evaluate the incidence of coronary heart disease (CHD) in extremely obese patients. Methods and results Between 2005 and 2015 we investigated retrospectively 23,359 patients undergoing ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf33d6d93f5c5ffd0b68ca581c692a8
https://pubmed.ncbi.nlm.nih.gov/27612569
https://pubmed.ncbi.nlm.nih.gov/27612569
Autor:
H. Kuhn, Thorsten Lawrenz, Ludger Obergassel, F. Gietzen, Frank Lieder, Christian Leuner, Christoph Stellbrink
Publikováno v:
Clinical Research in Cardiology. 95:254-260
Relatively few reports on the clinical impact of atrial fibrillation (AF) in hypertrophic obstructive cardiomyopathy (HOCM) are available. The aims of our study are to report the effect of transcoronary ablation of septal hypertrophy (TASH) on clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e95e2869ed60b50658ace2d3d5d220
https://doi.org/10.1007/s00392-006-0372-0
https://doi.org/10.1007/s00392-006-0372-0
Autor:
Hans Neuser, F. Gietzen, Sebastian Kerber, Burghard Schumacher, Joachim Schümmelfeder, J. Brunn
Publikováno v:
Herz Kardiovaskul�re Erkrankungen. 30:102-110
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease phenotypically expressed in the general population at about 0.2%. Annual mortality rate is about 1% in unselected patients, 3-6% in patients with severe symptoms, and 17% following resusc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ca24c2f59e946eedcd90cc67f9b05ee
https://doi.org/10.1007/s00059-005-2675-8
https://doi.org/10.1007/s00059-005-2675-8
Publikováno v:
Zeitschrift für Herz-, Thorax- und Gefäßchirurgie. 18:i1-i5
Fur die Einschatzung von Patienten jenseits der 5. Lebensdekade mit fortgeschrittener Herzinsuffizienz ist die Klarung der Genese der Herzinsuffizienz vorrangig. Danach erfolgt die Optimierung der medikamentosen Therapie. In der folgenden Beobachtung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69386a2e595359ae317b35e7848d95a3
https://doi.org/10.1007/s00398-004-1105-1
https://doi.org/10.1007/s00398-004-1105-1
Publikováno v:
Heart. 90:638-644
To evaluate symptomatic and haemodynamic results of transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy in elderly patients.Tertiary referral centre for patients with hypertrophic obstructive cardiomyopathy.Retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d042d570b15ac6af7d875336f9f570d
https://doi.org/10.1136/hrt.2003.017509
https://doi.org/10.1136/hrt.2003.017509
Publikováno v:
Zeitschrift für Kardiologie. 91:575-580
Hypertrophic obstructive cardiomyopathy (HOCM) and long-QT syndrome (LQTS) are cardiac diseases with known genetic disorders. They are inherited in an autosomal-dominant way. From a clinical point of view, both diseases share a disturbed repolarizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f1d0e366d594ad577d51ae83b3bb013
https://doi.org/10.1007/s00392-002-0811-5
https://doi.org/10.1007/s00392-002-0811-5